SURG vs TLF

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 15, 2026

SURG

47.1
AI Score
VS
SURG Wins

TLF

48.2
AI Score

Investment Advisor Scores

SURG

47score
Recommendation
HOLD

TLF

48score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric SURG TLF Winner
Forward P/E 3.4722 11.7096 SURG
PEG Ratio 0.5333 5.9186 SURG
Revenue Growth 40.7% 1.5% SURG
Earnings Growth -77.7% -98.0% SURG
Tradestie Score 47.1/100 48.2/100 TLF
Profit Margin -47.9% -2.1% TLF
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

SURG 1M: -48.4% · 3M: -64.5% TLF 1M: +2.0% · 3M: +13.0%

Current Technical Phase

SURG

Markdown
Sell / avoid

Price below a falling SMA50 (slope -29.3%), weak momentum, RSI 34

RSI (14): 33.5 · Price: $0.15

TLF

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.7% over 20 days), RSI 56

RSI (14): 56.1 · Price: $2.61

Fundamentals Snapshot

Metric SURG TLF
Market Cap
Forward P/E 3.2 11.7
Trailing P/E
Revenue (TTM)
Revenue Growth 0.4% 0.0%
Gross Margin -0.2% 0.6%
Operating Margin 0.2% 0.0%
EPS -1.49 -0.16
Dividend Yield 0.00%

Frequently Asked Questions

Based on our detailed analysis, SURG is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.